• Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

BlackRock Global Funds - World Healthscience Fund

+ Add to Watchlist

MERHLEA:LX

23.24 EUR 0.15 0.65%

As of 00:59:30 ET on 08/21/2014.

Snapshot for BlackRock Global Funds - World Healthscience Fund (MERHLEA)

Year To Date: +17.97% 3-Month: +11.25% 3-Year: +29.25% 52-Week Range: 17.92 - 23.24
1-Month: +5.30% 1-Year: +28.82% 5-Year: +19.43% Beta vs NDWUHC: 0.97

Mutual Fund Chart for MERHLEA

No chart data available.
  • MERHLEA:LX 23.24
  • 1M
  • 1Y
Interactive MERHLEA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for MERHLEA

BlackRock Global Funds - World Healthscience Fund is an open-end Fund incorporated in Luxembourg. The Fund's objective is to maximize growth in United States dollars. The Fund invests globally in equities of companies with substantial interests in healthcare, pharmaceuticals and medical technology and supplies.

Inception Date: 04-06-2001 Telephone: 352-34-20-101
Managers: THOMAS P CALLAN / H ERIN XIE
Web Site: www.blackrockinternational.com

Fundamentals for MERHLEA

NAV (on 2014-08-21) 23.24
Assets (M) (on 2014-07-31) 2,348.23
Fund Leveraged N
Minimum Investment 5,000.00
Minimum Subsequent Investment 1,000.00

Dividends for MERHLEA

No dividends reported

Fees & Expenses for MERHLEA

Front Load 5.00
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.84

Top Fund Holdings for MERHLEA

Filing Date: 06/30/2014
Name Position Value % of Total
Johnson & Johnson 1,132,500 118,482,150 5.011%
Merck & Co Inc 1,682,900 97,355,765 4.117%
Novartis AG 984,800 89,173,929 3.771%
AbbVie Inc 1,469,500 82,938,580 3.507%
Roche Holding AG 273,300 81,515,392 3.447%
Biogen Idec Inc 223,700 70,534,847 2.983%
Pfizer Inc 2,374,200 70,466,256 2.980%
Covidien PLC 722,600 65,164,068 2.756%
Bayer AG 459,000 64,823,571 2.741%
Celgene Corp 748,108 64,247,515 2.717%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil